Genetic characteristics of toxigenic Clostridia and toxin gene evolution

Toxicon

Volumn 75, Issue , 2013, Pages 63-89

  Popoff, Michel R ^a   Bouvet, Philippe ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Clostridium; Evolution; Genetics; Toxin

Indexed keywords

AEROLYSIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL TOXIN; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN E; BOTULINUM TOXIN F; CLOSTRIDIUM BETA2 TOXIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; CLOSTRIDIUM EPSILON TOXIN; CLOSTRIDIUM IOTA TOXIN; CLOSTRIDIUM TOXIN; ENTEROTOXIN; GENTAMICIN; STREPTOMYCIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL VIRULENCE; BACTERIOPHAGE; CHROMOSOME VARIANT; CLOSTRIDIA; CLOSTRIDIUM ARGENTINENSE; CLOSTRIDIUM BARATII; CLOSTRIDIUM BIFERMENTANS; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM BUTYRICUM; CLOSTRIDIUM CHAUVOEI; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM HAEMOLYTICUM; CLOSTRIDIUM HISTOLYTICUM; CLOSTRIDIUM NOVYI; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM SORDELLII; CLOSTRIDIUM SPETICUM; CLOSTRIDIUM SPIROFORME; CLOSTRIDIUM TETANI; FOOD POISONING; GANGRENE; GENE CLUSTER; GENE INSERTION SEQUENCE; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENETIC RECOMBINATION; GENETIC VARIABILITY; HORIZONTAL GENE TRANSFER; MOLECULAR EVOLUTION; MUSCLE NECROSIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; TRANSPOSON;

ANIMALIA; BACTERIA (MICROORGANISMS); BASIDIOMYCOTA; CLOSTRIDIA; CLOSTRIDIUM; CLOSTRIDIUM ARGENTINENSE; CLOSTRIDIUM BARATII; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM BUTYRICUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM NOVYI; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM SORDELLII; EUKARYOTA;

CLOSTRIDIUM; EVOLUTION; GENETICS; TOXIN;

BACTERIAL TOXINS; BOTULINUM TOXINS; CALCIUM-BINDING PROTEINS; CHROMOSOMES, BACTERIAL; CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; ENTEROTOXINS; EVOLUTION, MOLECULAR; GENE TRANSFER, HORIZONTAL; GENES, BACTERIAL; GENETIC LOCI; GENETIC VARIATION; PLASMIDS; PORE FORMING CYTOTOXIC PROTEINS; PROTEIN CONFORMATION; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; TYPE C PHOSPHOLIPASES;

EID: 84885302477     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2013.05.003     Document Type: Article

References (247)

1. Abraham L.J., Rood J.I. Identification of Tn4451 and Tn4452, chloramphenicol resistance transposons from Clostridium perfringens. J. Bacteriol. 1987, 169:1579-1584.
2. Adams V., Lyras D., Farrow K.A., Rood J.I. The clostridial mobilisable transposons. Cell Mol. Life Sci. 2002, 59:2033-2043.
3. Ahmed S.A., Byrne M.P., Jensen M., Hines H.B., Brueggemann E., Smith L.A. Enzymatic autocatalysis of botulinum A neurotoxin light chain. J. Protein Chem. 2001, 20:221-231.
4. Alouf J.E. Molecular features of the cytolytic pore forming bacterial protein toxins. Folia Microbiol. 2003, 48:5-16.
5. Anderluh G., Lakey J.H. Disparate proteins use similar architectures to damage membranes. Trends Biochem. Sci. 2008, 33:482-490.
6. Arndt E.R., Jacobson M.J., Abola E.E., Forsyth C.M., Tepp W.H., Marks J.D., Johnson E.A., Stevens E.S. A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4. J. Mol. Biol. 2006, 362:733-742.
7. Bannam T.L., Teng W.L., Bulach D., Lyras D., Rood J.I. Functional identification of conjugation and replication regions of the tetracycline resistance plasmid pCW3 from Clostridium perfringens. J. Bacteriol. 2006, 188:4942-4951.
8. Bannam T.L., Yan X.X., Harrison P.F., Seemann T., Keyburn A.L., Stubenrauch C., Weeramantri L.H., Cheung J.K., McClane B.A., Boyce J.D., Moore R.J., Rood J.I. Necrotic enteritis-derived Clostridium perfringens strain with three closely related independently conjugative toxin and antibiotic resistance plasmids. MBio 2011, 2.
9. Barash J.R., Arnon S.S. Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism. J. Clin. Microbiol. 2004, 42:1713-1715.
10. Barth H., Aktories K., Popoff M.R., Stiles B.G. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol. Mol. Biol. Rev. 2004, 68:373-402.
11. Bennik M.H.J., Mauchline M., Bosveld F., Elmore M., Minton N.P., Parkhill J., Peck M.W. The genome sequence of proteolytic Clostridium botulinum ATCC3502 (Hall A): some highlights. Clostridial 03 Pathogenesis, Woods Hole 2003, 44. L. Sonenshein (Ed.).
12. Billington S.J., Wieckowski E.U., Sarker M.R., Bueschel D., Songer J.G., McClane B.A. Clostridium perfringens type E animal enteritis isolates with highly conserved, silent enterotoxin gene sequences. Infect. Immun. 1998, 66:4531-4536.
13. Bouvet P.J., Popoff M.R. Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR. J. Clin. Microbiol. 2008, 46:3703-3713.
14. Braun V., Hundsberger T., Leukel P., Sauerborn M., von Eichel-Streiber C. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 1996, 181:29-38.
15. Braun V., Mehlig M., Moos M., Rupnik M., Kalt B., Mahony D.E., von Eichel-Streiber C. A chimeric ribozyme in Clostridium difficile combines features of group I introns and insertion elements. Mol. Microbiol. 2000, 36:1447-1459.
16. Briggs D.C., Naylor C.E., Smedley J.G., Lukoyanova N., Robertson S., Moss D.S., McClane B.A., Basak A.K. Structure of the food-poisoning Clostridium perfringens enterotoxin reveals similarity to the aerolysin-like pore-forming toxins. J. Mol. Biol. 2011, 413:138-149.
17. Brouwer M.S., Warburton P.J., Roberts A.P., Mullany P., Allan E. Genetic organisation, mobility and predicted functions of genes on integrated, mobile genetic elements in sequenced strains of Clostridium difficile. PLoS One 2011, 6:e23014.
18. Brüggemann H., Bäumer S., Fricke W.F., Wiezr A., Liesagang H., Decker I., Herzberg C., Martinez-Arias R., Henne A., Gottschalk G. The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1316-1321.
19. Brüggemann H., Wolher A., Mazuet C., Popoff M.R. Clostridium botulinum. Genomes of Food- and Water Borne Pathogens 2011, 185-212. ASM, Washington DC. P. Fratamico, Y. Liu, S. Kathariou (Eds.).
20. Brynestad S., Granum P.E. Evidence that Tn5565, which includes the enterotoxin gene in Clostridium perfringens, can have a circular form, which may be a transposition intermediate. FEMS Microbiol. Lett. 1999, 170:281-286.
21. Brynestad S., Sarker M.R., McClane B.A., Granum P.E., Rood J.I. The enterotoxin (CPE) plasmid from Clostridium perfringens is conjugative. Infect. Immun. 2001, 69:3483-3487.
22. Bueschel D.M., Jost B.H., Billington S.J., Trinh H.T., Songer J.G. Prevalence of cpb2, encoding beta2 toxin, in Clostridium perfringens field isolates: correlation of genotype with phenotype. Vet. Microbiol. 2003, 94:121-129.
23. Carter A.T., Paul C.J., Mason D.R., Twine S.M., Alston M.J., Logan S.M., Austin J.W., Peck M.W. Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum. BMC Genomics 2009, 10:115.
24. Carter G.P., Douce G.R., Govind R., Howarth P.M., Mackin K.E., Spencer J., Buckley A.M., Antunes A., Kotsanas D., Jenkin G.A., Dupuy B., Rood J.I., Lyras D. The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog. 2011, 7:e1002317.
25. Carter G.P., Lyras D., Allen D.L., Mackin K.E., Howarth P.M., O'Connor J.R., Rood J.I. Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J. Bacteriol. 2007, 189:7290-7301.
26. Cartman S.T., Kelly M.L., Heeg D., Heap J.T., Minton N.P. Precise manipulation of the Clostridium difficile chromosome reveals a lack of association between the tcdC genotype and toxin production. Appl. Environ. Microbiol. 2012, 78:4683-4690.
27. Chalmers G., Bruce H.L., Hunter D.B., Parreira V.R., Kulkarni R.R., Jiang Y.F., Prescott J.F., Boerlin P. Multilocus sequence typing analysis of Clostridium perfringens isolates from necrotic enteritis outbreaks in broiler chicken populations. J. Clin. Microbiol. 2008, 46:3957-3964.
28. Chaves-Olarte E., Freer E., Parra A., Guzman-Verri C., Moreno E., Thelestam M. R-Ras glucosylation and transient RhoA activation determine the cytopathic effect produced by toxin B variants from toxin A-negative strains of Clostridium difficile. J. Biol. Chem. 2003, 278:7956-7963.
29. Chaves-Olarte E., Low P., Freer P., Norlin T., Weidmann M., von Eichel-Streiber C., Thelestam M. A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two tother large clostridial toxins. J. Biol. Chem. 1999, 274:11046-11052.
30. Chen Y., Korkeala H., Aarnikunnas J., Lindstrom M. Sequencing the botulinum neurotoxin gene and related genes in Clostridium botulinum type E strains reveals orfx3 and a novel type E neurotoxin subtype. J. Bacteriol. 2007, 189:8643-8650.
31. Cole A.R., Gibert M., Popoff M.R., Moss D.S., Titball R.W., Basak A. Clostridium perfringens e{open}-toxin shows structural similarity to the pore-forming toxin aerolysin. Nat. Struct. Mol. Biol. 2004, 11:797-798.
32. Collie R.E., McClane B.A. Evidence that the enterotoxin gene can be episomal in Clostridium perfringens isolates associated with non-food-borne human gastrointestinal diseases. J. Clin. Microbiol. 1998, 36:30-36.
33. Collins M.D., East A.K. Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins. J. Appl. Microbiol. 1997, 84:5-17.
34. Cordoba J.J., Collins M.D., East A.K. Studies on the genes encoding botulinum neurotoxin type A of Clostridium botulinum from a variety of sources. Syst. Appl. Microbiol. 1995, 18:13-22.
35. Coursodon C.F., Glock R.D., Moore K.L., Cooper K.K., Songer J.G. TpeL-producing strains of Clostridium perfringens type A are highly virulent for broiler chicks. Anaerobe 2012, 18:117-121.
36. Curry S.R., Marsh J.W., Muto C.A., O'Leary M.M., Pasculle A.W., Harrison L.H. tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J. Clin. Microbiol. 2007, 45:215-221.
37. DasGupta B.R. Botulinum neurotoxins: perspective on their existence and as polyproteins harboring viral proteases. J. Gen. Appl. Microbiol. 2006, 52:1-8.
38. De Colibus L., Sonnen A.F., Morris K.J., Siebert C.A., Abrusci P., Plitzko J., Hodnik V., Leippe M., Volpi E., Anderluh G., Gilbert R.J. Structures of lysenin reveal a shared evolutionary origin for pore-forming proteins and its mode of sphingomyelin recognition. Structure 2012, 20:1498-1507.
39. Deguchi A., Miyamoto K., Kuwahara T., Miki Y., Kaneko I., Li J., McClane B.A., Akimoto S. Genetic characterization of type A enterotoxigenic Clostridium perfringens strains. PLoS One 2009, 4:e5598.
40. Dineen S.S., Bradshaw M., Johnson E.A. Neurotoxin gene clusters in Clostridium botulinum type A strains: sequence comparison and evolutionary implications. Curr. Microbiol. 2003, 46:342-352.
41. Dineen S.S., Bradshaw M., Karasek C.E., Johnson E.A. Nucleotide sequence and transcriptional analysis of the type A2 neurotoxin gene cluster in Clostridium botulinum. FEMS Microbiol. Lett. 2004, 235:9-16.
42. Dingle K.E., Griffiths D., Didelot X., Evans J., Vaughan A., Kachrimanidou M., Stoesser N., Jolley K.A., Golubchik T., Harding R.M., Peto T.E., Fawley W., Walker A.S., Wilcox M., Crook D.W. Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One 2011, 6:e19993.
43. Dover N., Barash J.R., Arnon S.S. Novel Clostridium botulinum toxin gene arrangement with subtype A5 and partial subtype B3 botulinum neurotoxin genes. J. Clin. Microbiol. 2009, 47:2349-2350.
44. Dover N., Barash J.R., Hill K.K., Davenport K.W., Teshima H., Xie G., Arnon S.S. Clostridium botulinum strain Af84 contains three neurotoxin gene clusters: bont/A2, bont/F4 and bont/F5. PLoS One 2013, 8:e61205.
45. Doxey A.C., Lynch M.D., Muller K.M., Meiering E.M., McConkey B.J. Insights into the evolutionary origins of clostridial neurotoxins from analysis of the Clostridium botulinum strain A neurotoxin gene cluster. BMC Evol. Biol. 2008, 8:316.
46. Dunstone M.A., Tweten R.K. Packing a punch: the mechanism of pore formation by cholesterol dependent cytolysins and membrane attack complex/perforin-like proteins. Curr. Opin. Struct. Biol. 2012, 22:342-349.
47. Dupuy B., Govind R., Antunes A., Matamouros S. Clostridium difficile toxin synthesis is negatively regulated by TcdC. J. Med. Microbiol. 2008, 57:685-689.
48. East A.K., Bhandari M., Stacey J.M., Campbell K.D., Collins M.D. Organization and phylogenetic interrelationships of genes encoding components of the botulinum toxin complex in proteolytic Clostridium botulinum types A, B, and F: evidence of chimeric sequences in the gene encoding the nontoxic nonhemagglutinin component. Int. J. Syst. Bacteriol. 1996, 46:1105-1112.
49. Eisele K.H., Fink K., Vey M., Taylor H.V. Studies on the dissociation of botulinum neurotoxin type A complexes. Toxicon 2011, 57:555-565.
50. Eklund M.W., Dowell J. Avian Botulism 1987, Charles C. Thomas, Springfield, Ill.
51. Eklund M.W., Poysky F.T. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages. Appl. Microbiol. 1974, 27:251-258.
52. Eklund M.W., Poysky F.T., Habig W.H. Bacteriophages and plasmids in Clostridium botulinum and Clostridium tetani and their relationship to production of toxins. Botulinum Neurotoxin and Tetanus Toxin 1989, 25-51. Academic Press, San Diego. L.L. Simpson (Ed.).
53. Eklund M.W., Poysky F.T., Meyers J.A., Pelroy G.A. Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage. Science 1974, 172:480-482.
54. Eklund M.W., Poysky F.T., Peterson M.E., Meyers J.A. Relationship of bacteriophage to alpha toxin production in Clostridium novyi types A and B. Infect. Immun. 1976, 14:798-803.
55. Eklund M.W., Poysky F.T., Reed S.M., Smith C.A. Bacteriophage and the toxigenicity of Clostridium botulinum type C. Science 1971, 172:480-482.
56. Elliott B., Squire M.M., Thean S., Chang B.J., Brazier J.S., Rupnik M., Riley T.V. New types of toxin A-negative, toxin B-positive strains among clinical isolates of Clostridium difficile in Australia. J. Med. Microbiol. 2011, 60:1108-1111. (Epub 032011 Mar 031010). doi:1110.1099/jmm.1100.031062-031060.
57. Fenicia L., Franciosa G., Pourshaban M., Aureli P. Intestinal toxemia botulism in two young people, caused by Clostridium butyricum type E. Clin. Infect. Dis. 1999, 29:381-387.
58. Fisher D.J., Miyamoto K., Harrison B., Akimoto S., Sarker M.R., McClane B.A. Association of beta2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene. Mol. Microbiol. 2005, 56:747-762.
59. Forgetta V., Oughton M.T., Marquis P., Brukner I., Blanchette R., Haub K., Magrini V., Mardis E.R., Gerding D.N., Loo V.G., Miller M.A., Mulvey M.R., Rupnik M., Dascal A., Dewar K. Fourteen-genome comparison identifies DNA markers for severe-disease-associated strains of Clostridium difficile. J. Clin. Microbiol. 2011, 49:2230-2238.
60. Franciosa G., Fenicia L., Pourshaban M., Aureli P. Recovery of a strain of Clostridium botulinum producing both neurotoxin A and neurotoxin B from canned macrobiotic food. Appl. Environ. Microbiol. 1997, 63.
61. Franciosa G., Ferreira J.L., Hatheway C.L. Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms. J. Clin. Microbiol. 1994, 32:1911-1917.
62. Franciosa G., Floridi F., Maugliani A., Aureli P. Differentiation of the gene clusters encoding botulinum neurotoxin type A complexes in Clostridium botulinum type A, Ab, and A(B) strains. Appl. Environ. Microbiol. 2004, 70:7192-7199.
63. Franciosa G., Maugliani A., Floridi F., Aureli P. A novel type A2 neurotoxin gene cluster in Clostridium botulinum strain Mascarpone. FEMS Microbiol. Lett. 2006, 261:88-94.
64. Franciosa G., Maugliani A., Scalfaro C., Aureli P. Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains. PLoS One 2009, 4:e4829.
65. Garmory H.S., Chanter N., French N.P., Bueschel D., Songer J.G., Titball R.W. Occurrence of Clostridium perfringens beta2-toxin amongst animals, determined using genotyping and subtyping PCR assays. Epidemiol. Infect. 2000, 124:61-67.
66. Gibert M., Jolivet-Reynaud C., Popoff M.R. Beta2 toxin, a novel toxin produced by Clostridium perfringens. Gene 1997, 203:65-73.
67. Goldenberg S.D., French G.L. Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J. Infect. 2011, 62:355-362.
68. Govind R., Dupuy B. Secretion of Clostridium difficile toxins A and B requires the holin-like protein TcdE. PLoS Pathog. 2012, 8:e1002727.
69. Gu S., Rumpel S., Zhou J., Strotmeier J., Bigalke H., Perry K., Shoemaker C.B., Rummel A., Jin R. Botulinum neurotoxin is shielded by NTNHA in an interlocked complex. Science 2012, 335:977-981.
70. Gurjar A., Li J., McClane B.A. Characterization of toxin plasmids in Clostridium perfringens type C isolates. Infect. Immun. 2010, 78:4860-4869.
71. Hall J.D., McCroskey L.M., Pincomb B.J., Hatheway C.L. Isolation of an organism resembling Clostridium barati which produces type F botulinal toxin from an infant with botulism. J. Clin. Microbiol. 1985, 21:654-655.
72. Han S., Arvai A.S., Clancy S.B., Tainer J.A. Crystal structure and novel recognition motif of Rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis. J. Mol. Biol. 2001, 305:95-107.
73. Harrison B., Raju D., Garmory H.S., Brett M.M., Titball R.W., Sarker M.R. Molecular characterization of Clostridium perfringens isolates from humans with sporadic diarrhea: evidence for transcriptional regulation of the beta2-toxin-encoding gene. Appl. Environ. Microbiol. 2005, 71:8362-8370.
74. Harry K.H., Zhou R., Kroos L., Melville S.B. Sporulation and enterotoxin (CPE) synthesis are controlled by the sporulation-specific sigma factors SigE and SigK in Clostridium perfringens. J. Bacteriol. 2009, 191:2728-2742.
75. Hassan K.A., Paulsen I.T. Clostridium perfringens. Genomes of Foodborne and Waterborne Pathogens 2011, 213-221. ASM Press, Washington DC. P. Fratamico, Y. Liu, S. Kathariou (Eds.).
76. Hauser D., Gibert M., Boquet P.,R.,P.M. Plasmid localization of a type E botulinal neurotoxin gene homologue in toxigenic Clostridium butyricum strains, and absence of this gene in non-toxigenic C. butyricum strains. FEMS Microbiol. Lett. 1992, 99:251-256.
77. Hauser D., Gibert M., Eklund M.W., Boquet P., Popoff M.R. Comparative analysis of C3 and botulinal neurotoxin genes and their environment in Clostridium botulinum C and D. J. Bacteriol. 1993, 175:7260-7268.
78. He M., Sebaihia M., Lawley T.D., Stabler R.A., Dawson L.F., Martin M.J., Holt K.E., Seth-Smith H.M., Quail M.A., Rance R., Brooks K., Churcher C., Harris D., Bentley S.D., Burrows C., Clark L., Corton C., Murray V., Rose G., Thurston S., van Tonder A., Walker D., Wren B.W., Dougan G., Parkhill J. Evolutionary dynamics of Clostridium difficile over shortand long time scales. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7527-7532.
79. Henderson I., Davis T., Elmore M., Minton N. The genetic basis of toxin production in Clostridium botulinum and Clostridium tetani. The Clostridia: Molecular Biology and Pathogenesis 1997, 261-294. Academic Press, New York. I. Rood (Ed.).
80. Henderson I., Whelan S.M., Davis T.O., Minton N.P. Genetic characterization of the botulinum toxin complex of Clostridium botulinum strain NCTC2916. FEMS Microbiol. Lett. 1996, 140:151-158.
81. Henkel J.S., Jacobson M., Tepp W., Pier C., Johnson E.A., Barbieri J.T. Catalytic properties of botulinum neurotoxin subtypes A3 and A4. Biochemistry 2009, 48:2522-2528.
82. Heuck A.P., Hotze E.M., Tweten R.K., Johnson A.E. Mechanism of membrane insertion of a multimeric beta-barrel protein: perfringolysin O creates a pore using ordered and coupled conformational changes. Mol. Cell 2000, 6:1233-1242.
83. Hibberd M.C., Neumann A.P., Rehberger T.G., Siragusa G.R. Multilocus sequence typing subtypes of poultry Clostridium perfringens isolates demonstrate disease niche partitioning. J. Clin. Microbiol. 2011, 49:1556-1567.
84. Hielm S., Bjorkroth J., Hyytia E., Korkeala H. Genomic analysis of Clostridium botulinum group II by pulsed-field gel electrophoresis. Appl. Environ. Microbiol. 1998, 64:703-708.
85. Hielm S., Björkroth J., Hyytiä E., Korkeala H. Prevalence of Clostridium botulinum in Finnish trout farms: pulse-field gel electrophoresis typing reveals extensive genetic diversity among type E isolates. Appl. Environ. Microbiol. 1998, 64:4161-4167.
86. Hill K.K., Smith T.J., Helma C.H., Ticknor L.O., Foley B.T., Svensson R.T., Brown J.L., Johnson E.A., Smith L.A., Okinaka R.T., Jackson P.J., Marks J.D. Genetic diversity among botulinum neurotoxin-producing clostridial strains. J. Bacteriol. 2007, 189:818-832.
87. Hill K.K., Xie G., Foley B.T., Smith T.J., Munk A.C., Bruce D., Smith L.A., Brettin T.S., Detter J.C. Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains. BMC Biol. 2009, 7:66.
88. Hinderink K., Lindstrom M., Korkeala H. Group I Clostridium botulinum strains show significant variation in growth at low and high temperatures. J. Food Prot. 2009, 72:375-383.
89. Hong Y.H., Song W., Lee S.H., Lillehoj H.S. Differential gene expression profiles of beta-defensins in the crop, intestine, and spleen using a necrotic enteritis model in 2 commercial broiler chicken lines. Poult. Sci. 2012, 91:1081-1088. doi:1010.3382/ps.2011-01948.
90. Hookman P., Barkin J.S. Clostridium difficile associated infection, diarrhea and colitis. World J. Gastroenterol. 2009, 15:1554-1580.
91. Hotze E.M., Le H.M., Sieber J.R., Bruxvoort C., McInerney M.J., Tweten R.K. Identification and characterization of the first cholesterol-dependent cytolysins from Gram-negative bacteria. Infect Immun. 2013, 81:216-225.
92. Huang I.H., Waters M., Grau R.R., Sarker M.R. Disruption of the genes (spoOA) encoding sporulation transcription factor blocks endospore formation and enterotoxin production in enterotoxigenic Clostridium perfringens type A. FEMS Microbiol. Lett. 2004, 233:233-240.
93. Hughes M.L., Poon R., Adams V., Sayeed S., Saputo J., Uzal F.A., McClane B.A., Rood J.I. Epsilon-toxin plasmids of Clostridium perfringens type D are conjugative. J. Bacteriol. 2007, 189:7531-7538.
94. Hutson R.A., Collins M.D., East A.K., Thompson D.E. Nucleotide sequence of the gene coding for non-proteolytic Clostridium botulinum type B neurotoxin: comparison with other Clostridial neeurotoxins. Curr. Microbiol. 1994, 28:101-110.
95. Hutson R.A., Zhou Y., Collins M.D., Johnson E.A., Hatheway C.L., Sugiyama H. Genetic characterization of Clostridium botulinum type A containing silent type B neurotoxin gene sequences. J. Biol. Chem. 1996, 271:10786-10792.
96. Huyet J., Gilbert M., Popoff M.R., Basak A. Crystallization and preliminary X-ray diffraction of delta toxin from Clostridium perfringens. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun 2011, 67:369-371.
97. Hwang H.J., Lee J.C., Yamamoto Y., Sarker M.R., Tsuchiya T., Oguma K. Identification of structural genes for Clostridium botulinum type C neurotoxin-converting phage particles. FEMS Microbiol. Lett. 2007, 270:82-89.
98. Hyytia E., Bjorkroth J., Hielm S., Korkeala H. Characterisation of Clostridium botulinum groups I and II by randomly amplified polymorphic DNA analysis and repetitive element sequence-based PCR. Int. J. Food Microbiol. 1999, 48:179-189.
99. Hyytia E., Hielm S., Björkroth J., Korkeala H. Biodiversity of Clostridium botulinum type E strains isolated from fish and fishery products. Appl. Environ. Microbiol. 1999, 65:2057-2064.
100. Ihara H., Kohda T., Morimoto F., Tsukamoto K., Karasawa T., Nakamura S., Mukamoto M., Kozaki S. Sequence of the gene for Clostridium botulinum type B neurotoxin associated with infant botulism, expression of the C-terminal half of heavy chain and its binding activity. Biochim. Biophys. Acta 2003, 1625:19-26.
101. Inui K., Sagane Y., Miyata K., Miyashita S., Suzuki T., Shikamori Y., Ohyama T., Niwa K., Watanabe T. Toxic and nontoxic components of botulinum neurotoxin complex are evolved from a common ancestral zinc protein. Biochem. Biophys. Res. Commun. 2012, 419:500-504.
102. Jacobson M.J., Lin G., Raphael B., Andreadis J., Johnson E.A. Analysis of neurotoxin cluster genes in Clostridium botulinum strains producing botulinum neurotoxin serotype A subtypes. Appl. Environ. Microbiol. 2008, 74:2778-2786.
103. Jacobson M.J., Lin G., Whittam T.S., Johnson E.A. Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typing. Microbiology 2008, 154:2408-2415.
104. Jank T., Aktories K. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol. 2008, 16:222-229.
105. Johnson E.A., Tepp W., Bradshaw M., Gilbert R.J., Cook P.E., McIntosh E.D. Characterization of Clostridium botulinum strains associated with an infant botulism case in the United Kingdom. J. Clin. Microbiol. 2005, 43:2602-2607.
106. Jost B.H., Billington S.J., Trinh H.T., Bueschel D.M., Songer J.G. Atypical cpb2 genes, encoding beta2-toxin in Clostridium perfringens isolates of nonporcine origin. Infect Immun. 2005, 73:652-656.
107. Jost B.H., Billington S.J., Trinh H.T., Songer J.G. Association of genes encoding beta2 toxin and a collagen binding protein in Clostridium perfringens isolates of porcine origin. Vet. Microbiol. 2006, 115:173-182.
108. Jost B.H., Trinh H.T., Songer J.G. Clonal relationships among Clostridium perfringens of porcine origin as determined by multilocus sequence typing. Vet. Microbiol. 2006, 116:158-165. (Epub 2006 May 2002).
109. Jovita M.R., Collins M.D., East A.K. Gene organization and sequence determination of the two botulinum neurotoxin gene clusters in Clostridium botulinum. Curr. Microbiol. 1998, 36:226-231.
110. Justin N., Walker N., Bullifent H.L., Songer G., Bueschel D.M., Jost H., Naylor C., Miller J., Moss D.S., Titball R.W., Basak A.K. The first strain of Clostridium perfringens isolated from an avian source has an alpha-toxin with divergent structural and kinetics properties. Biochemistry 2002, 41:6253-6262.
111. Katayama S., Dupuy B., Daube G., China B., Cole S. Genome mapping of Clostridium perfringens strains with I-CeuI shows manyvirulence genes to be plamsid-borne. Mol. Gen. Genet. 1996, 251:720-726.
112. Keto-Timonen R., Nevas M., Korkeala H. Efficient DNA fingerprint of Clostridium botulinum types A, B, E, and F by amplified fragment length polymorphism analysis. Appl. Environ. Microbiol. 2005, 71:1148-1154.
113. Kintzer A.F., Sterling H.J., Tang II, Abdul-Gader A., Miles A.J., Wallace B.A., Williams E.R., Krantz B.A. Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma. J. Mol. Biol. 2010, 399:741-758. (Epub 2010 Apr 1028). doi:710.1016/j.jmb.2010.1004.1041.
114. Kitadokoro K., Nishimura K., Kamitani S., Fukui-Miyazaki A., Toshima H., Abe H., Kamata Y., Sugita-Konishi Y., Yamamoto S., Karatani H., Horiguchi Y. Crystal structure of Clostridium perfringens enterotoxin displays features of beta-pore-forming toxins. J. Biol. Chem. 2011, 286:19549-19555.
115. Knapp O., Stiles B.G., Popoff M.R. The aerolysin-like toxin family of cytolytic, pore-forming toxins. Open Toxinol. J. 2010, 3:53-68.
116. Knetsch C.W., Terveer E.M., Lauber C., Gorbalenya A.E., Harmanus C., Kuijper E.J., Corver J., van Leeuwen H.C. Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages. Infect. Genet. Evol. 2012, 12:1577-1585.
117. Kobayashi S., Wada A., Shibasaki S., Annaka M., Higuchi H., Adachi K., Mori N., Ishikawa T., Masuda Y., Watanabe H., Yamamoto N., Yamaoka S., Inamatsu T. Spread of a large plasmid carrying the cpe gene and the tcp locus amongst Clostridium perfringens isolates from nosocomial outbreaks and sporadic cases of gastroenteritis in a geriatric hospital. Epidemiol. Infect. 2009, 137:108-113.
118. Kozaki S., Kamata Y., Nishiki T., Kakinuma H., Maruyama H., Takahashi H., Karasawa T., Yamakawa K., Nakamura S. Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in Japan. Infect. Immun. 1998, 66:4811-4816.
119. Kronhardt A., Rolando M., Beitzinger C., Stefani C., Leuber M., Flatau G., Popoff M.R., Benz R., Lemichez E. Cross-reactivity of anthrax and C2 toxin: protective antigen promotes the uptake of botulinum C2I toxin into human endothelial cells. PLoS One 2011, 6:e23133.
120. Kubota T., Shirakawa S., Kozaki S., Isogai E., Isogai H., Kimura K., Fujii N. Mosaic structure of the nontoxic-nonhemagglutinating component gene in Clostridium botulinum type A strain isolated frominfant botulism in Japan. Biochem. Biophys. Res. Commun. 1996, 224:843-848.
121. Lahti P., Heikinheimo A., Johansson T., Korkeala H. Clostridium perfringens type A strains carrying a plasmid-borne enterotoxin gene (genotype IS1151-cpe or IS1470-like-cpe) as a common cause of food poisoning. J. Clin. Microbiol. 2008, 46:371-373.
122. Lebrun M., Filee P., Mousset B., Desmecht D., Galleni M., Mainil J.G., Linden A. The expression of Clostridium perfringens consensus beta2 toxin is associated with bovine enterotoxaemia syndrome. Vet. Microbiol. 2007, 120:151-157.
123. Lepp D., Gong J., Songer J.G., Boerlin P., Parreira V.R., Prescott J.F. Identification of accessory genome regions in poultry Clostridium perfringens isolates carrying the netB plasmid. J. Bacteriol. 2013, 195:1152-1166. (Epub 02013 Jan 01034). doi:1110.1128/JB.01032-01012.
124. Lepp D., Roxas B., Parreira V.R., Marri P.R., Rosey E.L., Gong J., Songer J.G., Vedantam G., Prescott J.F. Identification of novel pathogenicity loci in Clostridium perfringens strains that cause avian necrotic enteritis. PLoS One 2010, 5:e10795.
125. Lessa F.C., Gould C.V., McDonald L.C. Current status of Clostridium difficile infection epidemiology. Clin. Infect. Dis. 2012, 55:S65-S70.
126. Li J., Chen J., Vidal J.E., McClane B.A. The Agr-like quorum-sensing system regulates sporulation and production of enterotoxin and beta2 toxin by Clostridium perfringens type A non-food-borne human gastrointestinal disease strain F5603. Infect. Immun. 2011, 79:2451-2459.
127. Li J., McClane B.A. Evaluating the involvement of alternative sigma factors SigF and SigG in Clostridium perfringens sporulation and enterotoxin synthesis. Infect. Immun. 2010, 78:4286-4293.
128. Li J., Miyamoto K., McClane B.A. Comparison of virulence plasmids among Clostridium perfringens type E isolates. Infect. Immun. 2007, 75:1811-1819.
129. Li J., Miyamoto K., Sayeed S., McClane B.A. Organization of the cpe locus in CPE-positive Clostridium perfringens type C and D isolates. PLoS One 2010, 5:e10932.
130. Lindstrom M., Heikinheimo A., Lahti P., Korkeala H. Novel insights into the epidemiology of Clostridium perfringens type A food poisoning. Food Microbiol. 2011, 28:192-198.
131. Lindstrom M., Hinderink K., Somervuo P., Kiviniemi K., Nevas M., Chen Y., Auvinen P., Carter A.T., Mason D.R., Peck M.W., Korkeala H. Comparative genomic hybridization analysis of two predominant Nordic group I (proteolytic) Clostridium botulinum type B clusters. Appl. Environ. Microbiol. 2009, 75:2643-2651.
132. Lu Y., Sarson A.J., Gong J., Zhou H., Zhu W., Kang Z., Yu H., Sharif S., Han Y. Expression profiles of genes in toll-like receptor-mediated signaling of broilers infected with Clostridium perfringens. Clin. Vaccine Immunol. 2009, 16:1639-1647. (Epub 02009 Sep. 00223). doi:1610.1128/CVI.00254-00209.
133. Lyras D., Rood J.I. Transposition of Tn4451 and Tn4453 involves a circular intermediate that forms a promoter for the large resolvase, TnpX. Mol. Microbiol. 2000, 38:588-601.
134. Ma M., Li J., McClane B.A. Genotypic and phenotypic characterization of Clostridium perfringens isolates from Darmbrand cases in post-world war II Germany. Infect. Immun. 2012, 80:4354-4363. (Epub 02012 Oct 00811). doi:4310.1128/IAI.00818-00812.
135. Macdonald T.E., Helma C.H., Shou Y., Valdez Y.E., Ticknor L.O., Foley B.T., Davis S.W., Hannett G.E., Kelly-Cirino C.D., Barash J.R., Arnon S.S., Lindstrom M., Korkeala H., Smith L.A., Smith T.J., Hill K.K. Analysis of Clostridium botulinum serotype E strains by using multilocus sequence typing, amplified fragment length polymorphism, variable-number tandem-repeat analysis, and botulinum neurotoxin gene sequencing. Appl. Environ. Microbiol. 2011, 77:8625-8634.
136. Macdonald T.E., Helma C.H., Ticknor L.O., Jackson P.J., Okinaka R.T., Smith L.A., Smith T.J., Hill K.K. Differentiation of Clostridium botulinum serotype A strains by multiple-locus variable-number tandem-repeat analysis. Appl. Environ. Microbiol. 2008, 74:875-882.
137. Mani N., Dupuy B. Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5844-5849.
138. Manich M., Knapp O., Gibert M., Maier E., Jolivet-Reynaud C., Geny B., Benz R., Popoff M.R. Clostridium perfringens delta toxin is sequence related to beta toxin, NetB, and Staphylococcus pore-forming toxins, but shows functional differences. PLoS One 2008, 3:e3764.
139. Marshall K.M., Bradshaw M., Johnson E.A. Conjugative botulinum neurotoxin-encoding plasmids in Clostridium botulinum. PLoS One 2010, 5.
140. Marshall K.M., Bradshaw M., Pellet S., Johnson E.A. Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes. Biochem. Biophys. Res. Commun. 2007, 361:49-54.
141. Martin T.G., Smyth J.A. Prevalence of netB among some clinical isolates of Clostridium perfringens from animals in the United States. Vet. Microbiol. 2009, 136:202-205.
142. Marvaud J.C., Eisel U., Binz T., Niemann H., Popoff M.R. tetR is a positive regulator of the tetanus toxin gene in Clostridium tetani and is homologous to botR. Infect. Immun. 1998, 66:5698-5702.
143. McCroskey L.M., Hatheway C.L., Fenicia L., Pasolini B., Aureli P. Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. J. Clin. Microbiol. 1986, 23:201-202.
144. McCroskey L.M., Hatheway C.L., Woodruff B.A., Greenberg J.A., Jurgenson P. Type F botulism due to neurotoxigenic Clostridium baratii from an unknown source in an adult. J. Clin. Microbiol. 1991, 29:2618-2620.
145. Ménétrey J., Flatau G., Stura E.A., Charbonnier J.B., Gas F., Teulon J.M., Le Du M.H., Boquet P., Ménez A. NAD binding induces conformational changes in Rho ADP-ribosylating Clostridium botulinum C3 exoenzyme. J. Biol. Chem. 2002, 277:30950-30957.
146. Meng X., Karasawa T., Zou K., Kuang X., Wang X., Lu C., Wang C., Yamakawa K., Nakamura S. Characterization of a neurotoxigenic Clostridium butyricum strain isolated from the food implicated in an outbreak of food-borne type E botulism. J. Clin. Microbiol. 1997, 35:2160-2162.
147. Meng X., Yamakawa K., Zou K., Wang X., Kuang X., Lu C., Wang C., Karasawa T., Nakamura S. Isolation and characterization of neurotoxigenic Clostridium butyricum from soil in China. J. Med. Microbiol. 1999, 48:133-137.
148. Metcalf D.S., Weese J.S. Binary toxin locus analysis in Clostridium difficile. J. Med. Microbiol. 2011, 60:1137-1145.
149. Minton N.P. Molecular genetics of clostridial neurotoxins. Curr. Top. Microbiol. Immunol. 1995, 195:161-194.
150. Miyamoto K., Chakrabarti G., Morino Y., McClane B.A. Organization of the plasmid cpe locus in Clostridium perfringens type A isolates. Infect. Immun. 2002, 70:4261-4272.
151. Miyamoto K., Fisher D.J., Li J., Sayeed S., Akimoto S., McClane B.A. Complete sequencing and diversity analysis of the enterotoxin-encoding plasmids in Clostridium perfringens type A non-food-borne human gastrointestinal disease isolates. J. Bacteriol. 2006, 188:1585-1598.
152. Miyamoto K., Li J., Sayeed S., Akimoto S., McClane B.A. Sequencing and diversity analyses reveal extensive similarities between some epsilon-toxin-encoding plasmids and the pCPF5603 Clostridium perfringens enterotoxin plasmid. J. Bacteriol. 2008, 190:7178-7188.
153. Miyamoto K., Yumine N., Mimura K., Nagahama M., Li J., McClane B.A., Akimoto S. Identification of novel Clostridium perfringens type E strains that carry an iota toxin plasmid with a functional enterotoxin gene. PLoS One 2011, 6:e20376.
154. Moran Y., Fredman D., Szczesny P., Grynberg M., Technau U. Recurrent horizontal transfer of bacterial toxin genes to eukaryotes. Mol. Biol. Evol. 2012, 29:2223-2230.
155. Moriishi K., Koura M., Aba N., Fujii N., Fujinaga Y., Inoue K., Oguma K. Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D. Biochem. Biophys. Acta 1996, 1307:123-126.
156. Moriishi K., Koura M., Fujii N., Fujinaga Y., Inoue K., Syuto B., Oguma K. Molecular cloning of the gene encoding the mosaic neurotoxin, composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms. Appl. Environ. Microbiol. 1996, 62:662-667.
157. Myers G.S., Rasko D.A., Cheung J.K., Ravel J., Seshadri R., DeBoy R.T., Ren Q., Varga J., Awad M.M., Brinkac L.M., Daugherty S.C., Haft D.H., Dodson R.J., Madupu R., Nelson W.C., Rosovitz M.J., Sullivan S.A., Khouri H., Dimitrov G.I., Watkins K.L., Mulligan S., Benton J., Radune D., Fisher D.J., Atkins H.S., Hiscox T., Jost B.H., Billington S.J., Songer J.G., McClane B.A., Titball R.W., Rood J.I., Melville S.B., Paulsen I.T. Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Genome Res. 2006, 16:1031-1040.
158. Nakamura K., Kohda T., Umeda K., Yamamoto H., Mukamoto M., Kozaki S. Characterization of the D/C mosaic neurotoxin produced by Clostridium botulinum associated with bovine botulism in Japan. Vet. Microbiol. 2010, 140:147-154.
159. Nevas M., Lindström M., Hielm S., Björkroth K.J., Peck M.W., Korkeala H. Diversity of proteolytic Clostridium botulinum strains, determined by a pulse-field gel electrophoresis approach. Appl. Environ. Microbiol. 2005, 71:1311-1317.
160. Oguma K., Inoue K., Fujinaga Y., Yokota K., Watanabe T., Ohyama T., Takeshi K., Inoue K. Structure and function of Clostridium botulinum progenitor toxin. J. Toxicol. 1999, 18:17-34.
161. Olling A., Seehase S., Minton N.P., Tatge H., Schroter S., Kohlscheen S., Pich A., Just I., Gerhard R. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene. Microb. Pathog. 2012, 52:92-100.
162. Olson R., Nariya H., Yokota K., Kamio Y., Gouaux E. Crystal structure of staphylococcal LukF delineates conformational changes accompanying formation of a transmembrane channel. Nat. Struct. Biol. 1999, 6:134-140.
163. Parreira V.R., Costa M., Eikmeyer F., Blom J., Prescott J.F. Sequence of two plasmids from Clostridium perfringens chicken necrotic enteritis isolates and comparison with C. perfringens conjugative plasmids. PLoS One 2012, 7:e49753. (Epub 0042012 Nov 0049726). doi:49710.41371/journal.pone.0049753.
164. Peck M.W. Biology and genomic analysis of Clostridium botulinum. Adv. Microb. Physiol. 2009, 55:183-265. 320.
165. Peck M.W., Stringer S.C., Carter A.T. Clostridium botulinum in the post-genomic era. Food Microbiol. 2011, 28:183-191.
166. Perelle S., Gibert M., Bourlioux P., Corthier G., Popoff M.R. Production of a complete binary toxin (actin-specific ADP-ribosylating toxin) by Clostridium difficile CD196. Infect. Immun. 1997, 65:1402-1407.
167. Petit L., Gibert M., Popoff M.R. Clostridium perfringens: toxinotype and genotype. Trends Microbiol. 1999, 7:104-110.
168. Petosa C., Collier J.R., Klimpel K.R., Leppla S.H., Liddington R.C. Crystal structure of the anthrax toxin protective antigen. Nature (London) 1997, 385:833-838.
169. Popoff M.R. Molecular biology of actin-ADP-ribosylating toxins. Bacterial Protein Toxins 2000, 275-302. Springer, Berlin. K. Aktories, I. Just (Eds.).
170. Popoff M.R., Bouvet P. Clostridial toxins. Future Microbiol. 2009, 4:1021-1064.
171. Popoff M.R., Marvaud J.C. Structural and genomic features of clostridial neurotoxins. The Comprehensive Sourcebook of Bacterial Protein Toxins 1999, 174-201. Academic Press, London. second ed. J.E. Alouf, J.H. Freer (Eds.).
172. Popoff M.R., Rubin E.J., Gill D.M., Boquet P. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect. Immun. 1988, 56:2299-2306.
173. Porter C.J., Bantwal R., Bannam T.L., Rosado C.J., Pearce M.C., Adams V., Lyras D., Whisstock J.C., Rood J.I. The conjugation protein TcpC from Clostridium perfringens is structurally related to the type IV secretion system protein VirB8 from Gram-negative bacteria. Mol. Microbiol. 2012, 83:275-288. (Epub 02011 Dec 07911). doi:210.1111/j.1365-2958.2011.07930.x.
174. Poulain B., Popoff M.R., Molgo J. How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action. Botulinum J. 2008, 1:14-87.
175. Poulain B., Stiles B.G., Popoff M.R., Molgó J. Attack of the nervous system by clostridial toxins: physical findings, cellular and molecular actions. The Sourcebook of Bacterial Protein Toxins 2006, 348-389. Elsevier, Academic Press, Amsterdam. third ed. J.E. Alouf, M.R. Popoff (Eds.).
176. Poulet S., Hauser D., Quanz M., Niemann H., Popoff M.R. Sequences of the botulinal neurotoxin E derived from Clostridium botulinum type E (strain Beluga) and Clostridium butyricum (strains ATCC43181 and ATCC43755). Biochem. Biophys. Res. Commun. 1992, 183:107-113.
177. Prévost G., Mourey L., Colin D.A., Monteil H., Dalla sera M., Menestrina G. Alpha-helix and beta-barrel pore-forming toxins (leucocidins, alpha-, gamma-, and delta-cytolysins) of Staphylococcus aureus. The Comprehensive Sourcebook of Bacterial Protein Toxins 2006, 590-607. Elsevier Academic Press, Amsterdam. third ed. J.E. Alouf, M.R. Popoff (Eds.).
178. Pruitt R.N., Chumbler N.M., Rutherford S.A., Farrow M.A., Friedman D.B., Spiller B., Lacy D.B. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity. J. Biol. Chem. 2012, 287:8013-8020.
179. Raffestin S., Dupuy B., Marvaud J.C., Popoff M.R. BotR/A and TetR are alternative RNA polymerase sigma factors controlling the expression of the neurotoxin and associated protein genes in Clostridium botulinum type A and Clostridium tetani. Mol. Microbiol. 2005, 55:235-249.
180. Rakoff-Nahoum S., Medzhitov R. Innate immune recognition of the indigenous microbial flora. Mucosal Immunol. 2008, 1(Suppl. 1):S10-S14.
181. Raphael B.H., Choudoir M.J., Luquez C., Fernandez R., Maslanka S.E. Sequence diversity of genes encoding botulinum neurotoxin type F. Appl. Environ. Microbiol. 2010, 76:4805-4812.
182. Raphael B.H., Lautenschlager M., Kalb S.R., de Jong L.I., Frace M., Luquez C., Barr J.R., Fernandez R.A., Maslanka S.E. Analysis of a unique Clostridium botulinum strain from the Southern hemisphere producing a novel type E botulinum neurotoxin subtype. BMC Microbiol. 2012, 12:245.
183. Raphael B.H., Luquez C., McCroskey L.M., Joseph L.A., Jacobson M.J., Johnson E.A., Maslanka S.E., Andreadis J.D. Genetic homogeneity of Clostridium botulinum type A1 strains with unique toxin gene clusters. Appl. Environ. Microbiol. 2008, 74:4390-4397.
184. Reinert D.J., Jank T., Aktories K., Schulz G.E. Structural basis for the function of Clostridium difficile toxin B. J. Mol. Biol. 2005, 351:973-981.
185. Rood J.I. Virulence genes of Clostridium perfringens. Annu. Rev. Microbiol. 1998, 52:333-360.
186. Rooney A.P., Swezey J.L., Friedman R., Hecht D.W., Maddox C.W. Analysis of core housekeeping and virulence genes reveals cryptic lineages of Clostridium perfringens that are associated with distinct disease presentations. Genetics 2006, 172:2081-2092.
187. Rosenstiel P. Stories of love and hate: innate immunity and host-microbe crosstalk in the intestine. Curr. Opin. Gastroenterol. 2013, 29:125-132. doi:110.1097/MOG.1090b1013e32835da32832c32837.
188. Rossjohn J., Polekhina G., Feil S.C., Morton C.J., Tweten R.K., Parker M.W. Structures of perfringolysin O suggest a pathway for activation of cholesterol-dependent cytolysins. J. Mol. Biol. 2007, 367:1227-1236.
189. Rupnik M. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol. Rev. 2008, 32:541-555.
190. Rupnik M., Grabnar M., Geric B. Binary toxin producing Clostridium difficile strains. Anaerobe 2003, 9:289-294.
191. Rupnik M., Just I. Large clostridial cytotoxins modifying small GTPases. The Sourcebook of Bacterial Protein Toxins 2006, 409-429. Elsevier, Academic Press, Amsterdam. third ed. J.E. Alouf, M.R. Popoff (Eds.).
192. Sakaguchi Y., Hayashi H., Kurokawa K., Nakayama K., Oshima K., Fujinaga Y., Ohnishi M., Ohtsubo E., Hattori M., Oguma K. The genome sequence of Clostridium botulinum type C neurotoxin-converting phage and the molecular mechanisms of unstable lysogeny. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:17472-17477.
193. Sakaguchi Y., Hayashi T., Yamamoto Y., Nakayama K., Zhang K., Ma S., Arimitsu H., Oguma K. Molecular analysis of an extrachromosomal element containing the C2 toxin gene discovered in Clostridium botulinum type C. J. Bacteriol. 2009, 191:3282-3291.
194. Sansonetti P.J. The innate signaling of dangers and the dangers of innate signaling. Nat. Immunol. 2006, 7:1237-1242.
195. Santos-Buelga J., Collins M.D., East A.K. Characterization of the genes encoding the botulinum neurotoxin complex in a strain of Clostridium botulinum producing type B and F neurotoxins. Curr. Microbiol. 1998, 37:312-318.
196. Savva C.G., Fernandes da Costa S.P., Bokori-Brown M., Naylor C.E., Cole A.R., Moss D.S., Titball R.W., Basak A.K. Molecular architecture and functional analysis of NetB, a pore-forming toxin from Clostridium perfringens. J. Biol. Chem. 2013, 288:3512-3522.
197. Sawires Y.S., Songer J.G. Multiple-locus variable-number tandem repeat analysis for strain typing of Clostridium perfringens. Anaerobe 2005, 11:262-272.
198. Sawires Y.S., Songer J.G. Clostridium perfringens: insight into virulence evolution and population structure. Anaerobe 2006, 12:23-43.
199. Sayeed S., Li J., McClane B.A. Virulence plasmid diversity in Clostridium perfringens type D isolates. Infect. Immun. 2007, 75:2391-2398.
200. Sayeed S., Li J., McClane B.A. Characterization of virulence plasmid diversity among Clostridium perfringens type B isolates. Infect Immun. 2010, 78:495-504.
201. Sayeed S., Uzal F.A., Fisher D.J., Saputo J., Vidal J.E., Chen Y., Gupta P., Rood J.I., McClane B.A. Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model. Mol. Microbiol. 2008, 67:15-30.
202. Schallehn G., Eklund M.W., Brandis H. Phage conversion of Clostridium novyi type A. Zentralbl. Bakteriol. 1980, 247:95-100.
203. Schleberger C., Hochmann H., Barth H., Aktories K., Schulz G.E. Structure and action of the binary C2 toxin from Clostridium botulinum. J. Mol. Biol. 2006, 364:705-715.
204. Sebaihia M., Peck M.W., Minton N.P., Thomson N.R., Holden M.T., Mitchell W.J., Carter A.T., Bentley S.D., Mason D.R., Crossman L., Paul C.J., Ivens A., Wells-Bennik M.H., Davis I.J., Cerdeno-Tarraga A.M., Churcher C., Quail M.A., Chillingworth T., Feltwell T., Fraser A., Goodhead I., Hance Z., Jagels K., Larke N., Maddison M., Moule S., Mungall K., Norbertczak H., Rabbinowitsch E., Sanders M., Simmonds M., White B., Whithead S., Parkhill J. Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. Genome Res. 2007, 17:1082-1092.
205. Sebaihia M., Wren B.W., Mullany P., Fairweather N.F., Minton N., Stabler R., Thomson N.R., Roberts A.P., Cerdeno-Tarraga A.M., Wang H., Holden M.T., Wright A., Churcher C., Quail M.A., Baker S., Bason N., Brooks K., Chillingworth T., Cronin A., Davis P., Dowd L., Fraser A., Feltwell T., Hance Z., Holroyd S., Jagels K., Moule S., Mungall K., Price C., Rabbinowitsch E., Sharp S., Simmonds M., Stevens K., Unwin L., Whithead S., Dupuy B., Dougan G., Barrell B., Parkhill J. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 2006, 38:779-786.
206. Sharma S.K., Ramzan M.A., Singh B.R. Separation of the components of type A botulinum neeurotoxin complex by electrophoresis. Toxicon 2003, 41:321-331.
207. Shatursky O., Heuck A., Shepard L., Rossjhon J., Parker M., Johnson A., Tweten R. The mechanism of membrane insertion of a cholesterol-dependent cytolysin: a novel paradigm for pore-forming toxins. Cell 1999, 99:293-299.
208. Shimizu T., Ohtani K., Hirakawa H., Ohshima K., Yamashita A., Shiba T., Ogasawara N., Hattori M., Kuhara S., Hayashi H. Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:996-1001.
209. Skarin H., Hafstrom T., Westerberg J., Segerman B. Clostridium botulinum group III: a group with dual identity shaped by plasmids, phages and mobile elements. BMC Genomics 2011, 12:185.
210. Skarin H., Segerman B. Horizontal gene transfer of toxin genes in Clostridium botulinum: involvement of mobile elements and plasmids. Mob Genet. Elem. 2011, 1:213-215.
211. Smith L.D.S. Clostridium tetani. The Pathogenic Anaerobic Bacteria 1975, 177-201. Charles C. Thomas Publisher, Springfield Ill. L.D.S. Smith (Ed.).
212. Smith T.J., Hill K.K., Foley B.T., Detter J.C., Munk A.C., Bruce D.C., Doggett N.A., Smith L.A., Marks J.D., Xie G., Brettin T.S. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids. PLoS One 2007, 2:e1271.
213. Smith T.J., Lou J., Geren I.N., Forsyth C.M., Tsai R., Laporte S.L., Tepp W.H., Bradshaw M., Johnson E.A., Smith L.A., Marks J.D. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect. Immun. 2005, 73:5450-5457.
214. Soge O.O., Tivoli L.D., Meschke J.S., Roberts M.C. A conjugative macrolide resistance gene, mef(A), in environmental Clostridium perfringens carrying multiple macrolide and/or tetracycline resistance genes. J. Appl. Microbiol. 2009, 106:34-40. (Epub 02008 Dec 03911). doi:10.1111/j.1365-2672.2008.03960.x.
215. Song L., Hobaugh M.R., Shustak C., Cheley S., Bayley H., Gouaux J.E. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 1996, 274:1859-1866.
216. Spigaglia P., Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J. Clin. Microbiol. 2003, 40:3470-3475.
217. Stabler R.A., Dawson L.F., Valiente E., Cairns M.D., Martin M.J., Donahue E.H., Riley T.V., Songer J.G., Kuijper E.J., Dingle K.E., Wren B.W. Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS One 2012, 7:e31559.
218. Stabler R.A., He M., Dawson L., Martin M., Valiente E., Corton C., Lawley T.D., Sebaihia M., Quail M.A., Rose G., Gerding D.N., Gibert M., Popoff M.R., Parkhill J., Dougan G., Wren B.W. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 2009, 10:R102.
219. Stabler R.A., Valiente E., Dawson L.F., He M., Parkhill J., Wren B.W. In-depth genetic analysis of Clostridium difficile PCR-ribotype 027 strains reveals high genome fluidity including point mutations and inversions. Gut Microbes 2010, 1:269-276.
220. Stackebrandt E., Hippe H. Taxonomy and systematics. Clostridia 2001, 19-48. Willey-VCH, Weinheim. H. Bahl, P. Dürre (Eds.).
221. Stare B.G., Delmee M., Rupnik M. Variant forms of the binary toxin CDT locus and tcdC gene in Clostridium difficile strains. J. Med. Microbiol. 2007, 56:329-335.
222. Steen J.A., Bannam T.L., Teng W.L., Devenish R.J., Rood J.I. The putative coupling protein TcpA interacts with other pCW3-encoded proteins to form an essential part of the conjugation complex. J. Bacteriol. 2009, 191:2926-2933. (Epub 02009 Feb 00027). doi:2910.1128/JB.00032-00009.
223. Stiles B.G., Wigelsworth D.J., Popoff M.R., Barth H. Clostridial binary toxins: iota and c2 family portraits. Front. Cell Infect. Microbiol. 2011, 1:11.
224. Sting R. Detection of beta2 and major toxin genes by PCR in Clostridium perfringens field isolates of domestic animals suffering from enteritis or enterotoxaemia. Berl. Munch. Tierarztl. Wochenschr. 2009, 122:341-347.
225. Strom M.S., Eklund M.W., Poysky F.T. Plasmids in Clostridium botulinum and related species. Appl. Environ. Microbiol. 1984, 48:956-963.
226. Stubbs S., Rupnik M., Gibert M., Brazier J., Duerden B., Popoff M.R. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol. Lett. 2000, 186:307-312.
227. Suen J.C., Hatheway C.L., Steigerwalt A.G., Brenner D.J. Clostridium argentinense sp. nov.: a genetically homogeneous group composed of all strains of Clostridium botulinum toxin type G and some nontoxigenic strains previously identified as Clostridium subterminale or Clostridium hastiforme. Int. J. Syst. Bacteriol. 1988, 38:375-381.
228. Tabita K.S., Sakaguchi S., kozaki S., Sakaguchi G. Distinction between Clostridium botulinum type A strains associated with food-borne botulism and those with infant botulism in Japan in intraintestinal toxin production in infant mice and some other properties. FEMS Microbiol. Lett. 1991, 79:251-256.
229. Takeda M., Tsukamoto K., Kohda T., Matsui M., Mukamoto M., Kozaki S. Characterization of the neurotoxin produced by isolates associated with avian botulism. Avian Dis. 2005, 49:376-381.
230. Tan K.S., Wee B.Y., Song K.P. Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile. J. Med. Microbiol. 2000, 50:61619.
231. Teng W.L., Bannam T.L., Parsons J.A., Rood J.I. Functional characterization and localization of the TcpH conjugation protein from Clostridium perfringens. J. Bacteriol. 2008, 190:5075-5086. (Epub 02008 May 00316). doi:5010.1128/JB.00386-00308.
232. Titball R.W., Naylor C.E., Basak A.K. The Clostridium perfringens alpha-toxin. Anaerobe 1999, 5:51-64.
233. Tsutsui K., Minami J., Matsushita O., Katayama S., Taniguchi Y., Nakamura S., Nishioka M., Okabe A. Phylogenetic analysis of phospholipase C genes from Clostridium perfringens types A to E and Clostridium novyi. J. Bacteriol. 1995, 177:7164-7170.
234. Tweten R.K. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect. Immun. 2005, 73:6199-6209.
235. Valiente E., Dawson L.F., Cairns M.D., Stabler R.A., Wren B.W. Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage. J. Med. Microbiol. 2012, 61:49-56.
236. van Asten A.J., Allaart J.G., Meeles A.D., Gloudemans P.W., Houwers D.J., Grone A. A new PCR followed by MboI digestion for the detection of all variants of the Clostridium perfringens cpb2 gene. Vet. Microbiol. 2008, 127:412-416. (Epub 2007 Sep. 2026).
237. van Asten A.J., Nikolaou G.N., Grone A. The occurrence of cpb2-toxigenic Clostridium perfringens and the possible role of the beta2-toxin in enteric disease of domestic animals, wild animals and humans. Vet. J. 2010, 183:135-140.
238. Vedantam G., Clark A., Chu M., McQuade R., Mallozzi M., Viswanathan V.K. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response. Gut Microbes 2012, 3:121-134.
239. Vilei E.M., Schlatter Y., Perreten V., Straub R., Popoff M.R., Gibert M., Grone A., Frey J. Antibiotic-induced expression of a cryptic cpb2 gene in equine beta2-toxigenic Clostridium perfringens. Mol. Microbiol. 2005, 57:1570-1581.
240. Wang X., Maegawa T., Karazawa T., Kozaki S., Tsukamoto K., Gyobu Y., Yamakawa K., Oguma K., Sakaguchi Y., Nakamura S. Genetic analysis of type E botulism toxin-producing Clostridium butyricum strains. Appl. Environ. Microbiol. 2000, 66:4992-4997.
241. Waters M., Raju D., Garmory H.S., Popoff M.R., Sarker M.R. Regulated expression of the beta2-toxin gene (cpb2) in Clostridium perfringens type a isolates from horses with gastrointestinal diseases. J. Clin. Microbiol. 2005, 43:4002-4009.
242. Weickert M.J., Chambliss G.H., Sugiyama H. Production of toxin by Clostridium botulinum type A strains cured of plasmids. Appl. Environ. Microbiol. 1986, 51:52-56.
243. Willems A., East A.K., Lawson P.A., Collins M.D. Sequence of the gene coding for the neurotoxin of Clostridium botulinum type A associated with infant botulism: comparison with other clostridial neurotoxins. Res. Microbiol. 1993, 144:547-556.
244. Wren B.W. A family of clostridial and streptococcal ligand-binding proteins with conserved C-terminal repeat sequences. Mol. Microbiol. 1991, 5:797-803.
245. Yamakawa K., Karasawa T., Kakinuma H., Maruyama H., Takahashi H., Nakamura S. Emergence of Clostridium botulinum typeB-like nontoxigenic organisms in a patient with type B infant botulism. J. Clin. Microbiol. 1997, 35:2163-2164.
246. Yamashita K., Kawai Y., Tanaka Y., Hirano N., Kaneko J., Tomita N., Ohta M., Kamio Y., Yao M., Tanaka I. Crystal structure of the octameric pore of staphylococcal gamma-hemolysin reveals the beta-barrel pore formation mechanism by two components. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:17314-17319. (Epub 1110402011 Oct 1110402103). doi:17310.11073/pnas.1110402108.
247. Zhou Y., Sugiyama H., Johnson E.A. Transfer of neurotoxigenicity from Clostridium butyricum to a nontoxigenic Clostridium botulinum type E-like strain. Appl. Environ. Microbiol. 1993, 59:3825-3831.